{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:51:55Z","timestamp":1759366315309,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.annpat.2018.03.006","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T22:07:58Z","timestamp":1527113278000},"page":"153-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mise au point sur la prise en charge clinique et anatomo-pathologique des tumeurs m\u00e9lanocytaires de la conjonctive"],"prefix":"10.1016","volume":"38","author":[{"given":"Sandra","family":"Lassalle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Caujolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Leger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9lia","family":"Maschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauris","family":"Gastaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sacha","family":"Nahon-Esteve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette","family":"Thariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Baillif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annpat.2018.03.006_bib0235","first-page":"109","article-title":"Conjunctival tumors: review of clinical features, risks, biomarkers, and outcomes\u2014The 2017\u00a0J.\u00a0Donald M.\u00a0Gass lecture","volume":"6","author":"Shields","year":"2017","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.annpat.2018.03.006_bib0240","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.ophtha.2004.02.013","article-title":"Clinical survey of 1643\u00a0melanocytic and nonmelanocytic conjunctival tumors","volume":"111","author":"Shields","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.annpat.2018.03.006_bib0245","series-title":"Tumors of the eye and ocular adnexa. AFIP. Atlas of tumor pathology. S\u00e9ries 4. Fascicle 5","first-page":"16","author":"Font","year":"2006"},{"key":"10.1016\/j.annpat.2018.03.006_bib0250","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00008390-200008000-00006","article-title":"Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100\u00a0protein and HMB-45","volume":"10","author":"Heegaard","year":"2000","journal-title":"Melanoma Res"},{"key":"10.1016\/j.annpat.2018.03.006_bib0255","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archophthalmol.2009.394","article-title":"Immunohistochemical studies of conjunctival nevi and melanomas","volume":"128","author":"Jakobiec","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0260","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/archophthalmol.2009.171","article-title":"Immunohistochemical studies of atypical conjunctival melanocytic nevi","volume":"127","author":"Jakobiec","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0265","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.5858\/2009-0522-RAR.1","article-title":"Melanocytic lesions of the conjunctiva","volume":"134","author":"Zembowicz","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.annpat.2018.03.006_bib0270","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1600-0560.2008.01041.x","article-title":"Nevi with site-related atypia: a review of melanocytic nevi with atypical histologic features based on anatomic site","volume":"35","author":"Hosler","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0275","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/PAS.0b013e31815143f3","article-title":"Juvenile conjunctival nevus: clinicopathologic analysis of 33\u00a0cases","volume":"32","author":"Thiagalingam","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0280","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0161-6420(95)30836-6","article-title":"Prevalence of primary acquired melanosis and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome. A case-control study","volume":"102","author":"Seregard","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.annpat.2018.03.006_bib0285","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1442-9071.2008.01888.x","article-title":"Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging","volume":"36","author":"Damato","year":"2008","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0290","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/eye.2012.254","article-title":"Conjunctival melanoma and melanocytic intra-epithelial neoplasia","volume":"27","author":"Kenawy","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.annpat.2018.03.006_bib0295","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/107327481602300205","article-title":"Management of primary acquired melanosis, nevus, and conjunctival melanoma","volume":"23","author":"Kao","year":"2016","journal-title":"Cancer Control"},{"key":"10.1016\/j.annpat.2018.03.006_bib0300","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.pas.0000213339.32734.64","article-title":"Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: clinicopathologic analysis of 29\u00a0cases","volume":"31","author":"Sugiura","year":"2007","journal-title":"Am J Surg Pathol"},{"year":"2017","series-title":"Malignant, melanoma of the conjunctiva. AJCC cancer staging manual","key":"10.1016\/j.annpat.2018.03.006_bib0305"},{"key":"10.1016\/j.annpat.2018.03.006_bib0310","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.86.2.163","article-title":"Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study","volume":"86","author":"Anastassiou","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0315","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/bjo.78.4.252","article-title":"Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256\u00a0cases","volume":"78","author":"Paridaens","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0320","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0161-6420(89)32920-4","article-title":"Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva","volume":"96","author":"Jakobiec","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.annpat.2018.03.006_bib0325","first-page":"64","article-title":"Histologic features of conjunctival melanoma predictive of metastasis and death (an American Ophthalmological thesis)","volume":"110","author":"Esmaeli","year":"2012","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.annpat.2018.03.006_bib0330","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.ophtha.2009.04.012","article-title":"Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30\u00a0patients","volume":"116","author":"Savar","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.annpat.2018.03.006_bib0335","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0560.2010.01625.x","article-title":"Conjunctival melanoma: local-regional control rates, and impact of high-risk histopathologic features","volume":"38","author":"Savar","year":"2011","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0340","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/02713680701648019","article-title":"Prognostic significance of histopathology of primary conjunctival melanoma in Caucasians","volume":"32","author":"Tuomaala","year":"2007","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.annpat.2018.03.006_bib0345","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.survophthal.2016.06.001","article-title":"Advances in the management of conjunctival melanoma","volume":"62","author":"Vora","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0350","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/aos.13007","article-title":"BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions","volume":"94","author":"Larsen","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0355","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1002\/cncr.26724","article-title":"NRAS mutation status is an independent prognostic factor in metastatic melanoma","volume":"118","author":"Jakob","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2018.03.006_bib0360","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(14)60958-2","article-title":"Anti-programmed-death-receptor-1\u00a0treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1\u00a0trial","volume":"384","author":"Robert","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.annpat.2018.03.006_bib0365","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1158\/1078-0432.CCR-13-0163","article-title":"Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas","volume":"19","author":"Griewank","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.annpat.2018.03.006_bib0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/aos.13100","article-title":"Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile","volume":"94","author":"Larsen","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0375","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamaophthalmol.2015.3200","article-title":"A retrospective review of conjunctival melanoma presentation, treatment, and outcome and an investigation of features associated with BRAF mutations","volume":"133","author":"Larsen","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0380","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1167\/iovs.04-0093","article-title":"BRAF mutations in conjunctival melanoma","volume":"45","author":"Gear","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.annpat.2018.03.006_bib0385","doi-asserted-by":"crossref","first-page":"58021","DOI":"10.18632\/oncotarget.10770","article-title":"Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy","volume":"8","author":"Cao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.annpat.2018.03.006_bib0390","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/CMR.0000000000000197","article-title":"Identification and clinical relevance of PD-L1\u00a0expression in primary mucosal malignant melanoma of the head and neck","volume":"25","author":"Thierauf","year":"2015","journal-title":"Melanoma Res"},{"key":"10.1016\/j.annpat.2018.03.006_bib0395","doi-asserted-by":"crossref","first-page":"54722","DOI":"10.18632\/oncotarget.18039","article-title":"PD-L1\/PD-1\u00a0expression and tumor-infiltrating lymphocytes in conjunctival melanoma","volume":"8","author":"Cao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.annpat.2018.03.006_bib0400","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1186\/s12885-016-2657-7","article-title":"A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib","volume":"16","author":"Maleka","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.annpat.2018.03.006_bib0405","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1097\/IOP.0000000000000833","article-title":"Conjunctival melanoma responsive to combined systemic BRAF\/MEK inhibitors","volume":"33","author":"Dagi Glass","year":"2017","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.annpat.2018.03.006_bib0410","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1158\/1078-0432.CCR-13-2007","article-title":"Conjunctival melanomas harbor BRAF and NRAS mutations\u2014Letter","volume":"19","author":"Weber","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.annpat.2018.03.006_bib0415","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4172\/2155-9570.1000322","article-title":"Conjunctival melanoma and BRAF inhibitor therapy","volume":"5","author":"Pahlitzsch","year":"2014","journal-title":"J Clin Exp Ophthalmol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0420","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamaophthalmol.2017.2279","article-title":"Pembrolizumab for recurrent conjunctival melanoma","volume":"135","author":"Kini","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0425","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/IOP.0000000000000790","article-title":"Immune checkpoint inhibitors for treatment of metastatic melanoma of the orbit and ocular adnexa","volume":"33","author":"Ford","year":"2017","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.annpat.2018.03.006_bib0430","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/IIO.0000000000000051","article-title":"Sentinel lymph node biopsy for eyelid and conjunctival tumors: what is the evidence?","volume":"55","author":"Mendoza","year":"2015","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.annpat.2018.03.006_bib0435","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/bjophthalmol-2013-303671","article-title":"Prospective study of sentinel lymph node biopsy for conjunctival melanoma","volume":"97","author":"Cohen","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0440","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2004.09.011","article-title":"Disseminated conjunctival melanoma","volume":"111","author":"Esmaeli","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.annpat.2018.03.006_bib0445","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ophtha.2003.11.001","article-title":"Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy","volume":"111","author":"Tuomaala","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.annpat.2018.03.006_bib0450","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000452473","article-title":"Systemic BRAF\/MEK inhibitors as a potential treatment option in metastatic conjunctival melanoma","volume":"3","author":"Mor","year":"2017","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.annpat.2018.03.006_bib0455","first-page":"121","article-title":"Pharmacotherapy and immunotherapy of conjunctival tumors","volume":"6","author":"Midena","year":"2017","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.annpat.2018.03.006_bib0460","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jfo.2009.10.016","article-title":"[Surgery and additional protontherapy for treatment of invasive and recurrent squamous cell carcinomas: technique and preliminary results]","volume":"32","author":"Caujolle","year":"2009","journal-title":"J Fr Ophtalmol"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649818300403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649818300403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:33:41Z","timestamp":1759332821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0242649818300403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0242649818300403"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2018.03.006","relation":{},"ISSN":["0242-6498"],"issn-type":[{"type":"print","value":"0242-6498"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mise au point sur la prise en charge clinique et anatomo-pathologique des tumeurs m\u00e9lanocytaires de la conjonctive","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2018.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}